Android app on Google Play

Obagi Medical Products, Inc. (OMPI) Tops Q2 EPS by 4c

August 2, 2012 5:33 PM EDT Send to a Friend
Obagi Medical Products, Inc. (NASDAQ: OMPI) reported Q2 EPS of $0.18, $0.04 better than the analyst estimate of $0.14. Revenue for the quarter came in at $30.5 million versus the consensus estimate of $30.39 million.

For earnings history and earnings-related data on Obagi Medical Products, Inc. (OMPI) click here.




You May Also Be Interested In


Related Categories

Earnings

Related Entities

Earnings

Add Your Comment